Medite Cancer Diagnostics, Inc. — Form D

Medite Cancer Diagnostics, Inc. of Orlando, FL, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-16. The offering totals $6.9M, of which $5.9M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Eric Eugene GoehausenDirectorOrlando, FL
Augusto Eugene OcanaDirectorOrlando, FL
Michael Eugene OttDirectorOrlando, FL
Michaela Eugene OttDirectorOrlando, FL
David Eugene PattersonDirectorOrlando, FL
David Eugene PattersonExecutive OfficerOrlando, FL
David Eugene PattersonPromoterOrlando, FL
Michael OttDirectorHopkins, MN
Michael OttExecutive OfficerHopkins, MN
Robert McCulloughDirectorNew York, NY
Robert McCulloughExecutive OfficerNew York, NY
John AbelesDirectorManassas, VA
John Austin Abeles, MDDirectorOrlando, FL
William Austin Lewis IVDirectorOrlando, FL
Joel Austin KanterDirectorOrlando, FL
Stephen Von RumpDirectorOrlando, FL
Stephen Von RumpExecutive OfficerOrlando, FL
Stephen Von RumpPromoterOrlando, FL
Gary PickettExecutive OfficerOrlando, FL
Gregory Austin FortunoffDirectorOrlando, FL
Stephen Lawrence Von RumpDirectorOrlando, FL
Stephen Lawrence Von RumpExecutive OfficerOrlando, FL
Stephen Lawrence Von RumpPromoterOrlando, FL
John Eugene Abeles, MDDirectorOrlando, FL
Stephen Eugene Von RumpDirectorOrlando, FL

Other filings by this issuer (10)

FiledFormOfferingSold
2018-10-26D$1.0M$870K
2018-07-12D$1.0M$850K
2018-02-22D$1.5M$1.2M
2017-03-09D$4.3M$555K
2017-02-09D$3.0M$412K
2016-11-03D/A$3.0M$400K
2016-11-02D$3.0M$400K
2016-06-03D$150K$150K
2016-01-11D$500K$500K
2014-04-16D$2.5M$1.5M

More